Intercure Ltd.
INCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857030
No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Intercure Ltd. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 19 | 20 | +1 |
| Shares | 3.10M | 3.46M | +355.6K (+11.5%) |
| Value | $5.30M | $5.43M | +$135.0K (+2.5%) |
New holders (3)
Institutions that held Intercure Ltd. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 705 | $1.11K | 0.00% |
| Jamison Private Wealth Management, Inc. | 201 | $316 | 0.00% |
| JPMorgan Chase & Co | 908 | – | – |
Sold out (2)
Institutions that held Intercure Ltd. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Millennium Management LLC | 22,946 | $39.0K |
| Davy Global Fund Management Ltd | 16,768 | $28.5K |